OncoArendi Therapeutics Overview
- Founded
- 2012

- Status
- Public
- Employees
- 86

- Stock Symbol
- OAT

- Share Price
- $13.53
- (As of Friday Closing)
OncoArendi Therapeutics General Information
Description
Oncoarendi Therapeutics SA is a biopharmaceutical company engaged in discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
Contact Information
- Żwirki i Wigury 101
- Warszawa, 02-089
- Poland
OncoArendi Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$13.53 | $13.20 | $1.96 - $21.22 | $188M | 13.9M | 43.7K | -$0.06 |
OncoArendi Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 57,834 | 26,391 | 36,360 | |
Revenue | 1 | 1 | 1 | 2 |
EBITDA | (875) | (1,197) | (1,406) | (671) |
Net Income | (862) | (1,085) | (1,231) | (636) |
Total Assets | 21,218 | 22,558 | 22,857 | 9,930 |
Total Debt | 748 | 1,007 | 0 | 0 |
OncoArendi Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore OncoArendi Therapeutics‘s full profile, request access.
Request a free trialOncoArendi Therapeutics Executive Team (3)
OncoArendi Therapeutics Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Sławomir Broniarek | OncoArendi Therapeutics | Chief Financial Officer & Board Member | 000 0000 |
Stanisław Pikul Ph.D | OncoArendi Therapeutics | Co-Founder, Vice President, Development & Board Member | 000 0000 |
OncoArendi Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial